Device for terminating arrhythmia by deceleration pacing

The signal evaluation device and the pulse generator generate an electrical pulse sequence that reduces the pulse repetition frequency, which solves the problems of low success rate and great side effects of central arrhythmia treatment in the prior art, and achieves a high-efficiency and low-electricity arrhythmia termination effect.

CN119095645APending Publication Date: 2024-12-06MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380036513.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-04-27
Filing Date
2023-04-26
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The existing equipment used to terminate arrhythmia in living hearts has a low success rate, and the current sensing during treatment leads to serious side effects such as tissue damage and post-traumatic stress.

Method used

The signal evaluation device is used to determine the spectrum of the electrical activity of the heart, and generate an electrical pulse sequence with reduced pulse repetition frequency through the pulse generator. The slow pace technique is used to terminate the arrhythmia. The pulse repetition frequency is reduced by at least 20% in the sequence, and does not depend on determination. Main frequency, use spectrum integration to set the start and end values ​​of the pulse repetition frequency to achieve the termination of arrhythmia under low electrical energy.

Benefits of technology

It improves the success rate of arrhythmia termination, reduces electrical energy use, reduces side effects, and achieves efficient arrhythmia treatment in real-time or near-real-time applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119095645A_ABST
    Figure CN119095645A_ABST
Patent Text Reader

Abstract

An apparatus (1) for determining an arrhythmia of a living heart (7) comprises signal evaluation means (3) for receiving a signal (6) representative of a current electrical activity of the heart (7) and determining a frequency spectrum (8, 11-13) of the signal (6). The device (1) further comprises a pulse generator (4) which generates a sequence (10) of electrical pulses (21) to be applied to the heart (7) at a pulse repetition frequency according to the frequency spectrum (8, 11-13) and the pulse repetition frequency is reduced by at least 20% over the sequence (10).
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a device for terminating arrhythmias in the heart of a living being. More particularly, the present invention relates to a device comprising the features of the preamble of claim 1.

[0002] In this application, the term "arrhythmia of the living heart" refers to all types of arrhythmias, including in particular ventricular and atrial fibrillation. Arrhythmias are a major cause of morbidity and mortality, with sudden cardiac death claiming hundreds of thousands of lives each year. The complex and chaotic dynamics of the underlying electrical excitation patterns in the heart are still not fully understood. However, it is known that spiral or vortex waves are the dominant driving spatiotemporal dynamics during arrhythmias. Background Art

[0003] Conventional treatment of ventricular fibrillation involves the application of electrical defibrillation pulses with the goal of restoring sinus rhythm. Because significant electrical currents are induced in the heart, this treatment is associated with severe side effects, including tissue damage and post-traumatic stress.

[0004] WO 2012 / 172 027A2 discloses a device for terminating a high-frequency arrhythmic electrical state of biological tissue. The device includes a sensor for providing an electrical signal representing the current electrical state of the biological tissue. A determination unit determines the main frequency of the current electrical state of the biological tissue according to the electrical signal, and determines whether the current electrical state of the biological tissue is a high-frequency electrical state according to the main frequency. In particular, if the main frequency is in the frequency range from 5Hz to 20Hz, the determination unit determines that the biological tissue is in a high-frequency arrhythmic electrical state. In addition, the determination unit determines a dominant level indicating how dominant the at least one main frequency is in the high-frequency arrhythmic electrical state, and triggers an electric pulse generator to generate a series of electric pulses according to the interval of the main frequency at a time point when the dominant level exceeds a predefined threshold. The electric pulse generator generates the series of electric pulses at corresponding intervals and corresponding numbers, so that the electric pulse grating scans the phase space defined by the main frequency once. In particular, the electric pulse generator generates electric pulses at corresponding intervals, so that the electric pulse grating scans the phase space at a phase interval in the range from π / 5 to 2π / 7. More specifically, the pulse generator generates electrical pulses at intervals exceeding 1 / 10 to 1 / 7 of the reciprocal value of the main frequency. Using known devices, applying electrical pulses with an electrical energy per pulse in the range of 1 / 100 to 1 / 10 of the standard cardiac defibrillation energy may be sufficient to terminate the high-frequency arrhythmic electrical state of biological tissue. In other words, the electrical pulse generator generates electrical pulses according to the so-called LEAP (Low Energy Anti-Fibrillation Pacing) concept at an electrical energy relatively low compared to the standard defibrillation energy used for defibrillation by providing a single pulse of electric shock. The effectiveness of the LEAP concept depends on the careful selection of the optimal starting point for applying the electrical pulses to the biological tissue.

[0005] WO 2017 / 157 954A1 discloses a device for applying at least one electrical pulse to living myocardial tissue, comprising an input terminal for receiving an electrical signal representing the current electrical activity of the myocardial tissue. A signal processor processes the electrical signal to determine a measure of the current complexity of the electrical signal in a state space, and outputs a control signal when the complexity measure is below a predetermined complexity threshold. A pulse generator generates at least one electrical pulse in response to the control signal. Via the output terminal, at least one electrical pulse is output to the myocardial tissue. In particular, the complexity measure is determined as the calculated current permutation entropy of the electrical signal. In this way, at least one electrical pulse should be triggered at an optimal time point so that the desired resetting effect of at least one electrical pulse on the living myocardial tissue is achieved at the lowest possible electrical energy. Summary of the invention

[0006] Problem of the Invention

[0007] The problem underlying the present invention is to improve the success rate of a device for terminating arrhythmias in a living heart.

[0008] Solution

[0009] The problem of the invention is solved by a device for terminating arrhythmias in a living heart comprising the features of claim 1. Preferred embodiments of the device are defined in the dependent claims.

[0010] Description of the Invention

[0011] The device for determining arrhythmias of a heart of a living subject according to the invention comprises a signal evaluation device which receives a signal representing the current electrical activity of the heart and determines the frequency spectrum of the signal. The device further comprises a pulse generator which generates a sequence of electrical pulses to be applied to the heart at a pulse repetition frequency according to the frequency spectrum, and the pulse repetition frequency is reduced by at least 20% over the sequence.

[0012] The arrhythmia may in particular be ventricular fibrillation (VF) or atrial fibrillation (AF). It may also be ventricular tachycardia (VT), for example.

[0013] The frequency spectrum may be, for example, the frequency spectrum of the amplitude or voltage of the signal, or preferably the frequency spectrum of the power density of the signal, ie the power spectral density (DSD).

[0014] Like most known devices for determining arrhythmias in a living heart, the device according to the invention may comprise a dedicated input for a signal representative of the current electrical activity of the heart, and a dedicated output for outputting a sequence of electrical pulses to be applied to the heart.

[0015] The pulse generator of the device according to the invention does not generate pulses of the train of electrical pulses at a fixed pulse repetition frequency (i.e. at fixed time intervals). Instead, the pulse repetition frequency is reduced over the train of electrical pulses, i.e. the electrical pulses are generated at time intervals which increase by at least 25% over their train. This concept is called "deceleration pacing".

[0016] In extensive research, the inventors of the present invention have found an optimal point in which arrhythmias of a living heart can be terminated with a relatively low electrical energy per pulse using an electrical pulse sequence with a constant pulse repetition frequency. Some of these optimal points are defined by areas of reduced efficiency of electrical pulses not only in the direction of even lower electrical energy per pulse, but also in the direction of higher electrical energy per pulse. Since hearts in real life vary greatly, these optimal points are difficult to find in practice. At least, it takes too much time to find them. Therefore, the inventors have thought of a method of utilizing the high efficiency of electrical pulses in such optimal points without actually finding the optimal point. One attempt is to use frequency scanning so that the pulse repetition frequency of the optimal point is included in the electrical pulse sequence at least in some way. In their experiments, the inventors found that scanning with a reduced pulse repetition frequency provides much better results than scanning with an increased pulse repetition frequency. In addition, they found criteria that can optimize the pulse repetition frequency process. This optimization goes far beyond the simple frequency scanning of the pulse repetition frequency that is intended to at least include an unknown optimal point in some way.

[0017] The pulse repetition frequency may start above the current dominant frequency of the signal representing the current electrical activity of the heart; and the pulse repetition frequency may drop well below the current dominant frequency. However, the signal evaluation means of the apparatus according to the invention do not need to determine any dominant frequency of the signal. Instead, other criteria may be applied in the process of setting the pulse repetition frequency on the electrical pulse sequence. These other criteria are more robust than the dominant frequency, and they do not even require the signal to have any dominant frequency that can be determined.

[0018] Typically, the pulse generator of the device according to the invention generates electrical pulse sequences such that their pulse repetition frequency decreases monotonically, preferably strictly monotonically. In a strictly monotonically decreasing pulse repetition frequency, the temporal distance between two consecutive electrical pulses will increase pulse by pulse.

[0019] Typically, the pulse generator of the device according to the invention will generate a sequence of electrical pulses such that the pulse repetition frequency of the electrical pulses decreases over the sequence by at least 30% of its starting value. This means that the time intervals at which the electrical pulses are generated increase over the sequence by more than 40% of their starting value. Typically, the pulse repetition frequency of the electrical pulses will decrease over the sequence by at least 50% of its starting value such that the time intervals at which subsequent electrical pulses follow one another increase by at least 100% of their starting value.

[0020] The pulse repetition frequency is generally reduced by no more than 80% of its initial value over the sequence and usually by no more than 70% of its initial value. This corresponds to an increase in the spacing of the electrical pulses by 500% and 333% of their initial value, respectively.

[0021] The pulse generator of the device according to the invention can generate at least 3 or 4 electrical pulses per sequence. The maximum number of electrical pulses per sequence can be 20 or 15. Thus, the number of electrical pulses is typically in the range of 4 to 15.

[0022] The pulse repetition frequency can be started with a fixed starting value, and the reduction of the pulse repetition frequency can be distributed linearly over the sequence of electrical pulses. However, the inventors have found that there are even better options for setting the starting value and distributing the reduction. These options are explained below:

[0023] The pulse generator can generate a sequence of electrical pulses so that the high-frequency part of the integral of the frequency spectrum down to the starting value of the pulse repetition frequency of the electrical pulses of the sequence is at least 5%, preferably at least 8%, and no more than 25%, preferably no more than 20% or even no more than 15% of the complete integral of the frequency spectrum. The integral of the frequency spectrum is the most preferred reference for the device according to the present invention when setting the pulse repetition frequency of the electrical pulses of the sequence. The integral can be limited to frequency, that is, calculated only for frequency, up to the maximum frequency associated with arrhythmias of the living heart. The upper cut-off frequency can be set, for example, to 20 Hz or 15 Hz or 10 Hz or even less, or to a frequency at which the signal significantly exceeds the background noise. With regard to ventricular tachycardia, the upper cut-off frequency can be set so that the harmonics of the main frequency of the tachycardia are not included in the integral. Therefore, the upper cut-off frequency can be set between the main frequency and twice the main frequency. Similarly, the integral can be limited to frequency, that is, calculated only for frequencies above the minimum frequency associated with arrhythmias of the living heart. The lower cut-off frequency can be set, for example, to 0.5 Hz or 1 Hz or even higher. The starting value of the pulse repetition frequency set using the integration defined above is clearly within the spectrum of the signal representing the current electrical activity of the heart in arrhythmia, but close to the upper end of said spectrum. In absolute terms, the starting value of the pulse repetition frequency of the electrical pulses of the sequence may be at least 5 Hz or at least 8 Hz and not more than 15 Hz or not more than 10 Hz. Typically, the starting value of the pulse repetition frequency will be lower when determined based on the PSD rather than on the amplitude spectrum.

[0024] Furthermore, the pulse generator of the device according to the invention can generate a sequence of electrical pulses such that the low-frequency part of the integration of the frequency spectrum up to the end value of the pulse repetition frequency of the electrical pulses of the sequence is at least 5%, preferably at least 8%, and not more than 25%, preferably not more than 20% or even not more than 15% of the complete integration of the frequency spectrum. In absolute terms, the end value of the pulse repetition frequency of the electrical pulses can be at least 0.5 Hz, at least 2 Hz, and not more than 6 Hz, preferably not more than 4 Hz. Thus, deceleration pacing can be interpreted as collecting the heart at different frequencies of the electrical activity of the heart present in arrhythmias and guiding the heart to a typical frequency of its sinusoidal electrical activity, said typical frequency being in the range of 1 Hz to 2 Hz.

[0025] The device according to the invention is most successful in terminating arrhythmias at low electrical energies of the applied electrical pulses if the pulse generator generates a sequence of electrical pulses such that the intermediate values ​​of the pulse repetition frequency of the electrical pulses of the sequence are set to divide the integral of the spectrum into approximately equal parts, preferably into equal parts within the limits of the temporal variation of the spectrum. In this way, the stronger the electrical activity of the heart, the higher the density of the intermediate values ​​of the pulse repetition frequency in the corresponding frequency range. Stronger electrical activity means that a higher effort may be required to collect the heart at the corresponding frequency before it can be guided to a regular sinusoidal electrical activity. In fact, for all arrhythmias modeled in the tests of this application, the result achieved with the device generating electrical pulses according to the above scheme (i.e. the arrhythmia termination rate) is equal to the best match of the start and end values ​​to the linear distribution of intermediate values ​​of the pulse repetition frequency. However, the best match can only be found through extensive testing, while the above scheme can be applied directly without testing and in real time or near real time as long as a signal representing the current electrical activity of the heart is available.

[0026] For example, the signal evaluation device can receive an ECG signal as a signal representing the electrical activity of the heart and determine the frequency spectrum of the ECG signal.

[0027] When determining the frequency spectrum of the signal representing the electrical activity of the heart, the signal evaluation device may Fourier transform the signal. This may be achieved by a fast Fourier transform or by any other computer-implemented Fourier transform that can be performed in real time or near real time. The signal may be Fourier transformed for a floating time window whose length may typically be in the range of 1 to 10 seconds.

[0028] When determining the spectrum of the signal on which the pulse repetition frequency of the electrical pulses is based, the signal evaluation device may average or smooth the preliminary spectrum of the signal representing the electrical activity of the heart. In other words, for setting the pulse repetition frequency based on the integration of the spectrum, the averaged or smoothed preliminary spectrum is used because it will provide a smoother integration process. Alternatively, the integration may be smoothed.

[0029] The pulse generator of the device according to the invention can generate a sequence of electrical pulses with equal voltage and energy of the pulses. However, in general, the voltage and energy of the pulses can vary over the sequence, in particular decrease. In absolute terms, the voltage and energy of each electrical pulse can be within the typical range of LEAP, i.e. within the range of 1 / 10 to 1 / 100 of the energy of a standard single defibrillation pulse. The shape of the electrical pulse can be equal to or similar to a typical defibrillation pulse, and the electrical pulse can be applied to the heart in the same manner as a typical defibrillation pulse.

[0030] It should be understood that the process of setting the pulse repetition rate of the sequence of electrical pulses according to the present invention does not replace the concept of applying the sequence of electrical pulses at an optimal time point. Although the arrhythmia termination success rate of the sequence of electrical pulses with decreasing pulse repetition rates set according to the present invention may be less dependent on application at an optimal time point, the present invention is preferably combined with the concept of applying the sequence of electrical pulses at an optimal time point.

[0031] Advantageous developments of the invention result from the claims, the description and the drawings.

[0032] The advantages of the features and combinations of features mentioned at the beginning of the description serve only as examples and may be used alternatively or cumulatively without these advantages necessarily having to be achieved according to embodiments of the invention.

[0033] The following applies to the disclosure of the original application and the patent, but not to the scope of protection: Further features can be derived from the drawings, in particular from the illustrated design and the dimensions of the multiple components relative to each other and from their relative arrangement and their operational connection. Combinations of features of different embodiments of the invention or of features of different claims independent of the selected references of the claims are also possible and are inspired thereby. This also relates to features shown in separate drawings or mentioned when describing them. These features may also be combined with features of different claims. Furthermore, other embodiments of the invention may not have the features mentioned in the claims, which, however, do not apply to the independent claims of the granted patent.

[0034] The number of features mentioned in the claims and description should be understood to cover the exact number and numbers greater than the mentioned number without the explicit use of the adverb "at least". For example, if it is mentioned that a pulse generator generates a sequence of electrical pulses, this should be understood that the pulse generator generates a sequence of exactly one electrical pulse or a sequence of two separate electrical pulses or even a sequence of more separate electrical pulses. Additional features may be added to these features or these may be the only features of the respective device.

[0035] Reference signs included in the claims do not limit the scope of the subject matter protected by the claims. Their only function is to make the claims easier to understand. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] In the following, the invention is further explained and described with reference to preferred exemplary embodiments shown in the drawings.

[0037] Figure 1 A device according to the invention is schematically shown.

[0038] Figure 2 The Fenton-Karma (FK) heart model shows the case of ventricular fibrillation (VF) according to Figure 1 Example of a frequency spectrum determined by an evaluation unit of a device.

[0039] Figure 3 Is an indication of the termination of the Fenton-Karma (FK) heart model according to Figure 2 Graph of the electrical energy required for ventricular fibrillation (VF) wherein the pulse repetition frequency of a sequence of five electrical pulses varies linearly between a starting frequency and an ending frequency, with the minimum success rate of 50%, ie the E50 value, indicated in grey shading.

[0040] Figure 4 is similar to Figure 3 , also involving a sequence of five electrical pulses, but indicating in grey shading the electrical energy required to terminate ventricular fibrillation (VF) with a minimum success rate of 90%, ie the E90 value.

[0041] Figure 5 is with Figure 3 Corresponding graph but involving a sequence of ten electrical pulses.

[0042] Figure 6 is corresponding to Figure 4 , but with Figure 5 Similarly, a sequence of ten electrical pulses is involved.

[0043] Figure 7 Shows Figure 1 One of the spectra of , whose integral is divided into eight equal parts by the starting value, the ending value and the seven intermediate values ​​of the pulse repetition frequency.

[0044] Figure 8 Shown according to Figure 7 The spectrum of Figure 7 Integration process for nine values ​​of the pulse repetition frequency.

[0045] Fig. 9 Shown according to Figure 7 and Figure 8Nine values ​​of pulse repetition frequency generate the electrical pulse train.

[0046] Fig.10 Is an indication of the termination of the Fenton-Karma (FK) heart model according to Figure 2 Graph of the electrical energy required to induce ventricular fibrillation (VF) with the minimum success rate of 50%, the E50 value, indicated in grey shading. Here, the pulse repetition frequency has been adjusted according to Figures 7 to 9 According to Figure 1 The three different spectra are set accordingly with cutoff frequencies of 10 Hz and 20 Hz. Fig.10 and Figure 3 The same white graphic symbols with black borders represent sequences with the same starting and ending frequencies.

[0047] Fig.11 is similar to Fig.10 , also involving a sequence of five electrical pulses, but indicating in grey shading the electrical energy required to terminate ventricular fibrillation (VF) with a minimum success rate of 90%, ie the E90 value. Fig.11 and Figure 4 The same white graphic symbols with black borders represent sequences with the same starting and ending frequencies.

[0048] Fig.12 is corresponding to Fig.10 , but involves Fig. 9 A sequence of ten electrical pulses is shown. Fig.12 and Figure 4 The same white graphic symbols with black borders represent sequences with the same starting and ending frequencies.

[0049] Fig.13 is corresponding to Fig.11 , but with Fig.12 Similarly, a sequence of ten electrical pulses is involved. Fig.13 and Figure 5 The same white graphic symbols with black borders represent sequences with the same starting and ending frequencies.

[0050] Fig.14 Dose-response curves for different pulse numbers used to terminate ventricular fibrillation in the Fenton-Karma (FK) heart model are shown. The pulse repetition frequency is based on Figures 7 to 9 based on Figure 1 In one of the spectrum settings, apply a cutoff frequency of 10Hz.

[0051] Fig.15 Shown with Fig.14 Similar dose-response curves, but with a cutoff frequency of 20 Hz applied.

[0052] Fig.16The Fenton-Karma (FK) heart model shows the case of ventricular tachycardia (VT) according to Figure 1 Example of a frequency spectrum determined by an evaluation unit of a device.

[0053] Figures 17 to 20 Corresponds to Figures 3 to 6 , but it is indicated that the termination in the Fenton-Karma (FK) heart model is based on Fig.16 A graph of the electrical energy required to produce a ventricular tachycardia (VT).

[0054] Figure 21 to Figure 24 Corresponds to Figures 10 to 13 , but it is indicated that the termination in the Fenton-Karma (FK) heart model is based on Fig.16 The energy curve of ventricular tachycardia (VT) is shown in Figure 2. The pulse repetition frequency is based on Figures 7 to 9 based on Fig.16 One of the frequency spectrum is set, applying cutoff frequencies of 5Hz and 10Hz. DETAILED DESCRIPTION

[0055] Figure 1 The device 1 schematically shown in comprises an input 2, a signal evaluation device 3, a pulse generator 4 and an output 5. The input 2 receives a signal 6 representing the current electrical activity of a living heart 7. The signal evaluation device 3 receives the signal 6 from the input 2 and determines a spectrum 8 of the signal 6. Furthermore, the signal evaluation device 3 determines from the spectrum 8 whether the current electrical activity of the heart 7 is an arrhythmia. In this case, the signal evaluation device 3 issues a trigger signal 9 which triggers the pulse generator 4. Based on the spectrum 8, the trigger pulse generator 4 generates a sequence of electrical pulses 10, which can be applied to the heart 7 via the output 5 in order to terminate the arrhythmia. The electrical pulses of the sequence 10 generated by the pulse generator 4 have a pulse repetition frequency which decreases over the sequence 10.

[0056] Figure 2 Three different frequency spectra 11 to 13 representing different signals 6 of the current electrical activity of a living heart are shown, as a function of Figure 1Practical example of spectrum 8 of . All of these spectra 11 to 13 are amplitude spectra. Spectrum 11 is determined as follows: the current membrane voltage of each individual pixel in the spatial domain of the heart 7 is Fourier transformed into a Fourier spectrum. The different Fourier spectra of the individual pixels are averaged. Spectrum 12 is determined by first spatially averaging the membrane voltages of the individual pixels to calculate a pseudo electrocardiogram (pECG), which is then Fourier transformed. Spectrum 12 therefore corresponds to the spectrum of the ECG signal from the heart 7. Spectrum 13 is determined by smoothing the strongly fluctuating spectrum 12. Although all three spectra 11 to 13 represent the same electrical activity of the heart 7, which is clearly an arrhythmia, namely ventricular fibrillation (VT), none of the three spectra clearly shows a dominant frequency. In addition, the peak frequencies 14 to 16 of the three spectra 11 to 13 vary by + / - 5%.

[0057] The electrical pulse sequence 10 generated by the pulse generator 4 scans a substantial part of the frequency spectrum of the signal 6 with its decreasing pulse repetition frequency.

[0058] Figure 3 Graph showing the energy of the electric pulses of a sequence 10 of five electric pulses required to terminate an arrhythmia of a heart model 7 with a minimum probability of 50% (E50 value) in a computer simulation, in arbitrary units as gray shading. Heart 7 is modeled according to Fenton, F. & Karma, A. Vortex dynamics in three-dimensional continuous myocardium of fiber rotation: fiber instability and fibrillation. Chaos: 8, 20-47, DOI: 10.1063 / 1.166311 (1998). The lighter the gray shading in the graph, the higher the energy of the electric pulse required to terminate the arrhythmia. The shaded area in the graph indicates that the arrhythmia cannot be terminated with a minimum probability of 50% with any electric pulse of suitable energy. The E50 values ​​are plotted on the starting frequency (i.e., the starting value of the pulse repetition frequency) and the ending frequency (i.e., the ending value of the pulse repetition frequency) of the corresponding sequence of electric pulses. Along the diagonal black line, the starting frequency and the ending frequency are equal. In the upper triangle of the graph, the end frequency is higher than the start frequency, and in the lower triangle of the graph, the start frequency is higher than the end frequency, which is a feature of the present invention. The black area on the right has a higher start frequency (in the range of 7 Hz to 10 Hz) and an end frequency (in the range of 3 Hz to 6 Hz), indicating a relatively low E50 value, i.e., an electrical pulse sequence 10 that terminates arrhythmia with low electrical pulse energy.

[0059] Figure 4is a graph indicating the electrical pulse energy of the electrical pulses of the five electrical pulse trains required to terminate an arrhythmia of the Fenton-Karma (FK) model of heart 7 with a 90% probability. As expected, gray shading generally indicates higher electrical pulse energy, and the shaded areas in the graph are larger. Areas with particularly low E90 values ​​are concentrated at start frequencies between 7 Hz and 10 Hz and end frequencies between 3 Hz and 6 Hz.

[0060] Figure 5 and Figure 6 Corresponds to Figure 3 and Figure 4 , except that the number of pulses in sequence 10 is ten instead of five. Here, the size of the shaded area corresponds to Figure 3 and Figure 5 In addition, from Figure 5 and Figure 6 A very interesting fact emerges from the comparison. Figure 5 The darkest areas in are concentrated at the starting frequencies between 8 Hz and 10 Hz and the ending frequencies between 7 Hz and 8 Hz, i.e. at a fairly low difference between the starting and ending frequencies, but Figure 6 The darkest areas in are concentrated at significantly lower end frequencies. This means that a high end probability requires a higher reduction in the pulse repetition frequency on the electrical pulse sequence 10.

[0061] Figures 7 and 8 The concept of setting the value of the pulse repetition frequency of the sequence according to the integration of the spectrum 11 is shown. Figure 7 Shown with Figure 1 The same spectrum 11, and Figure 8 The integral 17 of the spectrum 11, ie the area under the spectrum 11, is shown, which increases from 0 at a frequency of 0 Hz. The integral 17 is calculated up to a frequency of 20 Hz. By Figure 7 and Figure 8 The nine values ​​of pulse repetition frequency shown in 18-20 are based on Figure 8 The integral 17 is subdivided into ten equal parts, each part of the integral 17 corresponding to a 10% fraction of the full integral over the frequency range from 0 Hz to 20 Hz. These values ​​include the values ​​corresponding to Figures 3 to 6 The starting value 18 of the starting frequency shown in Figures 3 to 6 The end values ​​19 of the end frequencies, and the intermediate values ​​20, which are not arranged at equal distances in frequency, but are arranged with higher density in those areas where the spectrum shows higher values ​​indicating higher electrical activity of the heart 7 at the corresponding frequencies.

[0062] Fig. 9The resulting sequence 10 of electrical pulses 21 is shown starting with a start pulse 22, ending with an end pulse 23 and comprising eight intermediate pulses 14. The time interval or distance between pulses 21 increases with time and this increase is also not linear but reflects the shape of the spectrum 11.

[0063] With Figures 7 to 9 In the same manner as shown, the pulse repetition frequency of the sequence 10 of ten electrical pulses 21 can also be based on Figure 1 The other two spectra 12 and 13 shown in FIG. 1 or any other spectrum based on the signal representing the current electrical activity of the heart 7 can be set. Furthermore, it is not necessary to use individual spectra with frequencies up to 20 Hz. Instead, another cut-off value, such as 10 Hz, can be used, in particular when using Figure 2 Spectra 12 and 13 of , spectrum 12 and 13 have almost dropped to 0 at a frequency of 10Hz. In addition, refer to Figures 7 to 9 The explained principle can also be used to set the pulse repetition frequency for a sequence of any other number of electrical pulses 21 , for example five electrical pulses 21 .

[0064] for Fig.10 and Fig.11 The five pulses and Fig.12 and Fig.13 A sequence of ten pulses in Fig.10 and Fig.12 The E50 value and Fig.11 and Fig.13 The E90 value in Figures 3 to 6 The same grey shades are shown in Figure 2. Figure 2 The three spectra 11 to 13 of and the two different cutoff frequencies of 10 Hz and 20 Hz show the individual E50 and E90 values. Figures 10 to 13 The white graphic symbol with a black border in the figure refers to Figures 3 to 6 A white graphic symbol with a black border. Figure 3 and Fig.10 , Figure 4 and Fig.11 , Figure 5 and Fig.12 as well as Figure 6 and Fig.14 The same black-bordered white graphic symbols in refer to sequences with the same starting and ending frequencies. Figure 5 and Figure 6 A downward pointing triangle in and an arrow pointing to the right indicate that the corresponding sequence is outside the starting frequency range shown. Figures 3 to 6 The black-bordered white graphic symbols in the figure do not appear in the darkest areas of these figures, but Figures 10 to 13 All shades of gray shown are approximately equal to Figures 3 to 6This means that, independently of the spectrum 11 to 13 actually used and independently of the cutoff frequency of the integral 17 actually implemented, the Figures 7 to 9 The pulse repetition frequency is set to find the optimal or nearly optimal sequence 10 of electrical pulses 21, i.e., without an extensive search for the best combination of start and end frequencies. In practical use of an apparatus for terminating arrhythmias in a living heart, such an extensive search is not possible. Therefore, according to Figures 7 to 9 Setting the pulse repetition frequency (which can be done fully automatically and in real time or near real time) is a great advantage. Figures 7 to 9 Concept Figure 1 The device 1 will generate a sequence of electrical pulses of relatively low electrical pulse energy, but will still achieve a high success rate in terminating arrhythmias in any living heart 7 from which any signal 6 representing its electrical activity can be obtained and to which the sequence of low-energy electrical pulses 10 will be applied.

[0065] Fig.14 and Fig.15 The dose-response curves shown in are coded as follows. The continuous black line is based on Figure 2 Spectrum 13, that is, based on the amplitude spectrum, according to Figures 7 to 19 Dose-response curves for five pulses were generated. The continuous grey line shows the Figures 7 to 9 The five pulse cases are set based on the corresponding Figure 2 The dose-response curves of the pulse spectrum or pulse spectrum density (PSD) of the amplitude spectrum 13 are shown in FIG. The dose-response curve shown with a dashed line is the dose-response curve for 10 pulses, and the dose-response curve shown with a dashed line is the dose-response curve for 15 pulses, the pulse repetition frequency of which has been adjusted according to Figures 7 to 9 The dose-response curve shown with a dash-dot line relates to a comparative example achieved with 10 equally spaced pulses. Fig.14 and Fig.15 Shown according to Figures 7 to 9 Setting the pulse repetition frequency yields a large advantage over equidistant pulses. Furthermore, the success rate increases strongly from 5 to 10 pulses and further, less strongly, from 10 to 15 pulses. The differences between the dose-response curves for pulses whose pulse repetition frequency has been determined based on the amplitude or power spectrum are not very different, but the amplitude spectrum basis has a small advantage. Fig.15 The higher cutoff frequency of results in a slightly steeper increase in the success rate relative to the generalized energy, which is indicated as the energy per pulse.

[0066] Fig.16Examples of spectra 11 to 13 are shown in the case of ventricular tachycardia (VT) of the Fenton-Karma (FK) heart model. The spectra have been compared with the reference Figure 2 All spectra are amplitude spectra and show peaks at the main frequency 25 of VT and at the first harmonic 26 and second harmonic 27 of the main frequency 25. Figures 7 to 9 When determining the pulse repetition frequency of the pulses used to terminate the VT, the cutoff frequency of the integrator 17 can be set to a smaller value, such as 10 Hz or 5 Hz, the latter cutoff frequency excluding both harmonics 26 and 27.

[0067] Figures 17 to 24 It is shown that, also according to Fig.16 When terminating ventricular tachycardia (VT), Figures 7 to 9 Determine the pulse repetition frequency to obtain the success rate, see Figure 21 to Figure 24 , which is basically similar to Figures 17 to 20 The best success rate in the entire range of starting and ending frequencies is shown in . The device according to the invention is therefore suitable for terminating both fibrillation and tachycardia.

[0068] Reference numerals list

[0069] 1 Equipment

[0070] 2 Input

[0071] 3 Signal evaluation device

[0072] 4 Pulse generator

[0073] 5 Output

[0074] 6 Signal

[0075] 7 Heart

[0076] 8 Spectrum

[0077] 9 Trigger signal

[0078] 10 Sequence

[0079] 11 Spectrum, the average value of the spectrum of membrane voltage of each pixel in the spatial domain of heart 7

[0080] 12 PECG spectrum

[0081] 13 Spectrum, smoothed spectrum of PECG

[0082] 14 Peak of spectrum 11

[0083] 15 Peak of spectrum 12

[0084] 16 Peak of spectrum 13

[0085] 17 points

[0086] 18 Starting value

[0087] 19 End value

[0088] 20 Intermediate value

[0089] 21 Electric Pulse

[0090] 22 Start pulse

[0091] 23 End pulse

[0092] 24 Intermediate pulse

[0093] 25 Main frequency

[0094] 26 The first harmonic of the main frequency 25

[0095] 27 Second harmonic of the main frequency 25

Claims

1. A device (1) for terminating arrhythmia in a living heart (7), the device (1) comprising: - a signal evaluation device (3) configured to receive a signal (6) representing the current electrical activity of the heart (7) and to determine a frequency spectrum (8, 11-13) of the signal (6); as well as a pulse generator (4) configured to generate a sequence (10) of electrical pulses (21) to be applied to the heart (7) at a pulse repetition frequency according to said spectrum (8, 11-13), It is characterized in that the pulse generator (4) is configured to generate the sequence (10) of electrical pulses (21) such that the pulse repetition frequency of the electrical pulses (21) decreases by at least 20% over the sequence (10).

2. The device (1) according to claim 1, characterized in that The pulse generator (4) is configured to generate the sequence (10) of electrical pulses (21) such that the pulse repetition frequency decreases monotonically or strictly monotonically.

3. The device (1) according to claim 1 or 2, characterized in that The pulse generator (4) is configured to generate the sequence (10) of electrical pulses (21) such that a pulse repetition frequency of the electrical pulses (21) decreases over the sequence (10) by at least 30% or at least 50%.

4. The device (1) according to any one of the preceding claims, characterized in that The pulse generator (4) is configured to generate the sequence (10) of electrical pulses (21) such that a pulse repetition frequency of the electrical pulses (21) decreases by up to 80% or 70% over the sequence (10).

5. The device (1) according to any one of the preceding claims, characterized in that The pulse generator (4) is configured to generate a sequence (10) of electrical pulses (21) such that the sequence (10) consists of at least 3 or 4 electrical pulses (21) and no more than 20 or 15 electrical pulses (21).

6. Device (1) according to any one of the preceding claims, characterized in that The pulse generator (4) is configured to generate a sequence (10) of electrical pulses (21) such that a high-frequency portion of an integral (17) of the spectrum (8, 11-13) down to a starting value (18) of a pulse repetition frequency of the electrical pulses (21) of the sequence (10) is at least 5% or 8% and not more than 20% or 15% of a complete integral (17) of the spectrum (8, 11-13).

7. The device (1) according to any one of the preceding claims, characterized in that The pulse generator (4) is configured to generate the sequence (10) of electrical pulses (21) such that a starting value (18) of a pulse repetition frequency of the electrical pulses (21) of the sequence (10) is at least 5 Hz or 8 Hz and does not exceed 15 Hz or 10 Hz.

8. Device (1) according to any one of the preceding claims, characterized in that The pulse generator (4) is configured to generate the sequence (10) of electrical pulses (21) such that the low-frequency part of the integral (17) of the spectrum (8, 11-13) up to the end value (18) of the pulse repetition frequency of the electrical pulses (21) of the sequence (10) is at least 5% or 8% and not more than 20% or 15% of the complete integral (17) of the spectrum (8, 11-13).

9. The device (1) according to any one of the preceding claims, characterized in that The pulse generator (4) is configured to generate the sequence (10) of electrical pulses (21) such that an end value (19) of a pulse repetition frequency of the electrical pulses (21) of the sequence (10) is at least 0.5 Hz or 1 Hz and does not exceed 4 Hz or 2 Hz.

10. The device (1) according to any one of the preceding claims, characterized in that The pulse generator (4) is configured to generate the sequence (10) of electrical pulses (21) such that intermediate values ​​(20) of the pulse repetition frequency of the electrical pulses (21) of the sequence (10) are arranged to divide the complete integral (17) of the frequency spectrum (8, 11-13) into approximately equal parts.

11. The device (1) according to any one of the preceding claims, characterized in that The signal evaluation device (3) is configured to receive an ECG signal as the signal (6) representing the electrical activity of the heart (7) and to determine a frequency spectrum (12) of the ECG signal.

12. The device (1) according to any one of the preceding claims, characterized in that The signal evaluation device (3) is configured to Fourier transform the signal (6) representing the electrical activity of the heart (7) when determining the frequency spectrum (8, 11-13) of the signal (6).

13. The device (1) according to any one of the preceding claims, characterized in that The signal evaluation device (3) is configured to smooth a preliminary spectrum (8, 1-13) of the signal (6) when determining the spectrum (8, 11-13) of the signal (6) on which the pulse repetition frequency of the electrical pulses (21) is based.

14. The device (1) according to any one of the preceding claims, characterized in that The pulse generator (4) is configured to generate the sequence (10) of electrical pulses (21) such that the sequence (10) consists of pulses (21) of equal voltage and energy.